Literature DB >> 29892088

De novo truncating variants in WHSC1 recapitulate the Wolf-Hirschhorn (4p16.3 microdeletion) syndrome phenotype.

Nada Derar1, Zuhair N Al-Hassnan2,3, Mohammed Al-Owain2,3, Dorota Monies1,4, Mohamed Abouelhoda1,4, Brian F Meyer2,4, Nabil Moghrabi1, Fowzan S Alkuraya5,6,7.   

Abstract

PURPOSE: Wolf-Hirschhorn syndrome (WHS) is a genomic disorder with a recognizable dysmorphology profile caused by hemizygosity at 4p16.3. Previous attempts have failed to map the minimal critical locus to a single gene, leaving open the possibility that the core phenotypic components of the syndrome are caused by the combined haploinsufficiency of multiple genes.
METHODS: Clinical exome sequencing and "reverse" phenotyping.
RESULTS: We identified two patients with de novo truncating variants in WHSC1, which maps to the WHS critical locus. The phenotype of these two individuals is consistent with WHS, which suggests that haploinsufficiency of WHSC1 is sufficient to recapitulate the core phenotype (characteristic facies, and growth and developmental delay) of this classic microdeletion syndrome.
CONCLUSION: Our study expands the list of microdeletion syndromes that are solved at the single-gene level, and establishes WHSC1 as a disease gene in humans. Given the severe nature of the reported variants, the full phenotypic expression of WHSC1 may be further expanded by future reports of milder variants.

Entities:  

Keywords:  De novo; Exome; Intellectual disability; Methyltransferase

Mesh:

Substances:

Year:  2018        PMID: 29892088     DOI: 10.1038/s41436-018-0014-8

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  1 in total

1.  Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion.

Authors:  K Hirschhorn; H L Cooper; I L Firschein
Journal:  Humangenetik       Date:  1965
  1 in total
  9 in total

1.  Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing.

Authors:  David R Murdock; Hongzheng Dai; Lindsay C Burrage; Jill A Rosenfeld; Shamika Ketkar; Michaela F Müller; Vicente A Yépez; Julien Gagneur; Pengfei Liu; Shan Chen; Mahim Jain; Gladys Zapata; Carlos A Bacino; Hsiao-Tuan Chao; Paolo Moretti; William J Craigen; Neil A Hanchard; Brendan Lee
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 2.  Reprogramming of the epigenome in neurodevelopmental disorders.

Authors:  Khadija D Wilson; Elizabeth G Porter; Benjamin A Garcia
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-10-02       Impact factor: 8.697

3.  De novo loss-of-function variants in NSD2 (WHSC1) associate with a subset of Wolf-Hirschhorn syndrome.

Authors:  Elizabeth S Barrie; Maria P Alfaro; Ruthann B Pfau; Melanie J Goff; Kim L McBride; Kandamurugu Manickam; Erik J Zmuda
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-08-01

4.  The first familial NSD2 cases with a novel variant in a Chinese father and daughter with atypical WHS facial features and a 7.5-year follow-up of growth hormone therapy.

Authors:  Xuyun Hu; Di Wu; Yuchuan Li; Liya Wei; Xiaoqiao Li; Miao Qin; Hongdou Li; Mengting Li; Shaoke Chen; Chunxiu Gong; Yiping Shen
Journal:  BMC Med Genomics       Date:  2020-12-04       Impact factor: 3.063

5.  Alternatively Splicing Interactomes Identify Novel Isoform-Specific Partners for NSD2.

Authors:  Weidi Wang; Yucan Chen; Jingjing Zhao; Liang Chen; Weichen Song; Li Li; Guan Ning Lin
Journal:  Front Cell Dev Biol       Date:  2021-02-25

6.  Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma.

Authors:  Nargess Farhangdoost; Cynthia Horth; Bo Hu; Eric Bareke; Xiao Chen; Yinglu Li; Mariel Coradin; Benjamin A Garcia; Chao Lu; Jacek Majewski
Journal:  Cell Rep       Date:  2021-02-23       Impact factor: 9.423

Review 7.  From Wolf-Hirschhorn syndrome to NSD2 haploinsufficiency: a shifting paradigm through the description of a new case and a review of the literature.

Authors:  Luisa Cortellazzo Wiel; Irene Bruno; Egidio Barbi; Fabio Sirchia
Journal:  Ital J Pediatr       Date:  2022-05-12       Impact factor: 3.288

8.  De novo truncating variant in NSD2gene leading to atypical Wolf-Hirschhorn syndrome phenotype.

Authors:  Yanrui Jiang; Huizhen Sun; Qingmin Lin; Zengge Wang; Guanghai Wang; Jian Wang; Fan Jiang; Ruen Yao
Journal:  BMC Med Genet       Date:  2019-08-05       Impact factor: 2.103

9.  Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.

Authors:  Paolo Zanoni; Katharina Steindl; Deepanwita Sengupta; Or Gozani; Anita Rauch; Pascal Joset; Angela Bahr; Heinrich Sticht; Mariarosaria Lang-Muritano; Conny M A van Ravenswaaij-Arts; Marwan Shinawi; Marisa Andrews; Tania Attie-Bitach; Isabelle Maystadt; Newell Belnap; Valerie Benoit; Geoffroy Delplancq; Bert B A de Vries; Sarah Grotto; Didier Lacombe; Austin Larson; Jeroen Mourmans; Katrin Õunap; Giulia Petrilli; Rolph Pfundt; Keri Ramsey; Lot Snijders Blok; Vassilis Tsatsaris; Antonio Vitobello; Laurence Faivre; Patricia G Wheeler; Marijke R Wevers; Monica Wojcik; Markus Zweier
Journal:  Genet Med       Date:  2021-05-03       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.